Marketplace All-in-One How new ways to prevent RSV are savings lives and money
May 26, 2025
Explore the groundbreaking advancements in preventing RSV, including a vaccine for expectant mothers and antibodies for newborns, leading to a significant drop in infant hospitalizations. Discover the economic benefits of these measures for families and taxpayers alike. Delve into the rising financial distress experienced by older adults, particularly with credit card debt, and learn effective strategies for tackling this before retirement, including tailored budgeting and professional advice.
AI Snips
Chapters
Transcript
Episode notes
RSV Prevention Success
- New RSV prevention methods include a vaccine during pregnancy and antibodies given to newborns.
- These methods together significantly lowered RSV hospitalizations in infants, especially the youngest ones.
RSV Prevention Saves Money
- RSV infant hospitalizations cost taxpayers over $350 million annually, mostly paid by Medicaid.
- Preventing RSV saves money and reduces indirect costs like parents missing work and children's later asthma risk.
Vaccines' Economic Value
- Vaccines are among the best public health tools and very cost-effective.
- RSV prevention could yield long-term health and economic benefits similar to measles and polio vaccines.